AAVivo Revenue
Biotechnology Research • 
Houston, Texas, United States • 1-10 Employees
$
AAVivo revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at AAVivo
Anastasiya Smith
Vice President, Research and Development
Company overview
| Headquarters | Houston, Texas, United States |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
AAVivo Email Formats
AAVivo uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@virovek.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@virovek.com | 100% |
About AAVivo
AAVivo, Inc. is a pioneering biotechnology company based in Houston, Texas, that is developing novel, precision targeted biotherapeutics using its IntelligentAAV (iAAV) platform. The iAAV platform allows rapid development of precision biotherapies that can be produced by a patient’s body for potent, long-term disease control.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
AAVivo has never raised funding before.
Australia
Sweden
Japan
Latvia
United KingdomFrequently asked questions
AAVivo is located in Houston, Texas, US.
AAVivo generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
AAVivo has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
AAVivo has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
